On March 21, 2017, Alan W. Schoenbart, currently the Echo Therapeutics, Inc.’s Interim Chief Executive Officer and Chief Financial Officer, was appointed by the board of directors of the company to serve as Chief Executive Officer of the company. He will also continue as Chief Financial Officer. Mr. Schoenbart was also appointed by the Board as a director to serve in Class I to fill a vacancy on the Board.